Literature DB >> 7354236

Serum concentrations of C3 and C4 of the complement system in patients with chronic obstructive pulmonary disease.

R D Miller, F Kueppers, K P Offord.   

Abstract

In a search for host factors for the complex multifactoral disease, chronic obstructive pulmonary disease, we compared some major components of the complement system in 111 subjects with forced expiratory volumes in 1 sec less than 70% of predicted (index subjects) to those in 111 subjects matched as pairs for age, sex, smoking, and occupation having forced expiratory volumes in 1 sec more than 85% of predicted normal. Significantly lower blood levels of C3 and C4 were found in the index subjects (p less than 0.001). Among the index subjects there was a significant correlation between chronic cough and expectoration and low C3 and C4. There was not a significant correlation between low values and the frequency and severity of past respiratory infections. Levels of serum B globulin fraction, in which C3 and C4 migrate, were not different between the index and control subjects.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7354236

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  4 in total

1.  Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease.

Authors:  Paul A Kirkham; Gaetano Caramori; Paolo Casolari; Alberto A Papi; Matt Edwards; Betty Shamji; Kostas Triantaphyllopoulos; Farhana Hussain; Mariona Pinart; Younis Khan; Lucy Heinemann; Laurie Stevens; Mike Yeadon; Peter J Barnes; Kian F Chung; Ian M Adcock
Journal:  Am J Respir Crit Care Med       Date:  2011-10-01       Impact factor: 21.405

2.  Activation of C3a receptor is required in cigarette smoke-mediated emphysema.

Authors:  X Yuan; M Shan; R You; M V Frazier; M J Hong; R A Wetsel; S Drouin; A Seryshev; L-Z Song; L Cornwell; R D Rossen; D B Corry; F Kheradmand
Journal:  Mucosal Immunol       Date:  2014-12-03       Impact factor: 7.313

3.  Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD.

Authors:  Wei Sun; Katerina Kechris; Sean Jacobson; M Bradley Drummond; Gregory A Hawkins; Jenny Yang; Ting-Huei Chen; Pedro Miguel Quibrera; Wayne Anderson; R Graham Barr; Patricia V Basta; Eugene R Bleecker; Terri Beaty; Richard Casaburi; Peter Castaldi; Michael H Cho; Alejandro Comellas; James D Crapo; Gerard Criner; Dawn Demeo; Stephanie A Christenson; David J Couper; Jeffrey L Curtis; Claire M Doerschuk; Christine M Freeman; Natalia A Gouskova; MeiLan K Han; Nicola A Hanania; Nadia N Hansel; Craig P Hersh; Eric A Hoffman; Robert J Kaner; Richard E Kanner; Eric C Kleerup; Sharon Lutz; Fernando J Martinez; Deborah A Meyers; Stephen P Peters; Elizabeth A Regan; Stephen I Rennard; Mary Beth Scholand; Edwin K Silverman; Prescott G Woodruff; Wanda K O'Neal; Russell P Bowler
Journal:  PLoS Genet       Date:  2016-08-17       Impact factor: 5.917

4.  The role of complement activation in COPD exacerbation recovery.

Authors:  John-Paul Westwood; Alexander J Mackay; Gavin Donaldson; Samuel J Machin; Jadwiga A Wedzicha; Marie Scully
Journal:  ERJ Open Res       Date:  2016-10-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.